Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Management of novel treatments’ toxicities

Toxicities of TILs, CAR-Ts and bispecific antibodies

Date

21 Oct 2023

Session

Management of novel treatments’ toxicities

Topics

Cell-Based Therapy;  Management of Systemic Therapy Toxicities;  Immunotherapy

Tumour Site

Presenters

Anastasios Stathis

Authors

A. Stathis

Author affiliations

  • Medical Oncology Department, EOC - Ospedale Regionale Bellinzona e Valli - Istituto Oncologico della Svizzera Italiana (IOSI), 6500 - Bellinzona/CH

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion and Q&A

Presenter: Alice Indini

Session: Management of novel treatments’ toxicities

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.